AI Governance SOP Outline
Overview
This AI Governance SOP Outline provides a structured, ready-to-use foundation for drafting a Standard Operating Procedure that governs AI use in GMP-regulated pharmaceutical organizations. It helps teams define oversight, responsibilities, controls, and lifecycle expectations so AI adoption can proceed within a compliant and sustainable framework.
Who Is This For?
- Quality Assurance Directors
- Regulatory Compliance Officers
- IT Governance leads
- Digital Transformation teams
- SOP authors and document controllers
Use Cases
- Developing organizational AI governance framework
- Creating AI-specific SOPs for quality systems
- Establishing AI risk management procedures
- Defining roles and responsibilities for AI oversight
- Building AI lifecycle management processes
Download
The template is available in both editable Word format and PDF for printing or reference.
Key Benefits
- Time-saving: Provides a pre-structured SOP framework that reduces drafting effort
- GxP aligned: Designed to support GMP and broader GxP governance expectations
- Lifecycle coverage: Addresses the full AI lifecycle from intake through retirement
- Proactive compliance: Helps organizations respond to regulatory expectations before gaps emerge
- Flexible structure: Can be adapted to different quality systems, operating models, and governance committees
What the Template Covers
- Purpose and scope definition
- Roles and responsibilities matrix
- AI system inventory and classification
- Risk assessment and approval workflows
- Validation and change control requirements
- Training and competency requirements
- Periodic review and retirement procedures
Related Articles
- AI Integration in Pharmaceutical Quality Management
- AI in Pharmaceutical Quality Assurance
- Computer System Validation for AI Software
- AI and Change Control Risk Assessment
- Preparing for FDA Inspections: AI Systems
- AI in Pharmaceutical Training Systems
Disclaimer
This template is provided for educational and informational purposes only. It does not constitute regulatory advice, legal guidance, or a validated quality system document. Organizations should adapt this template to their specific regulatory requirements, quality management systems, and internal SOPs. Always consult with qualified regulatory and quality professionals before making compliance decisions.